The tyrosine kinase Pyk2 mediates lipopolysaccharide-induced IL-8 expression in human endothelial cells

Journal of Immunology

Volumn 180, Issue 8, 2008, Pages 5636-5644

  Anand, Appakkudal R ^a   Cucchiarini, Magali ^b   Terwilliger, Ernest F ^b   Ganju, Ramesh K ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE 2; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; TYRPHOSTIN; TYRPHOSTINS A9; UNCLASSIFIED DRUG; MAP3K8 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; ONCOPROTEIN; TYRPHOSTIN A9;

ARTICLE; CATALYSIS; CELL ACTIVATION; CELL ACTIVITY; CELL STIMULATION; CONTROLLED STUDY; DRUG INHIBITION; ENDOTHELIUM CELL; HUMAN; MIGRATION; MUTANT; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; BIOSYNTHESIS; DRUG EFFECT; IMMUNOLOGY; METABOLISM;

ENDOTHELIAL CELLS; FOCAL ADHESION KINASE 2; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MAP KINASE KINASE KINASES; NEUTROPHILS; PROTO-ONCOGENE PROTEINS; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 4; TYRPHOSTINS;

EID: 45949108853     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.8.5636     Document Type: Article

References (46)

1. Hack, C. E., and S. Zeerleder. 2001. The endothelium in sepsis: source of and a target for inflammation. Crit. Care Med. 29: S21-S27.
2. Trepels, T., A. M. Zeiher, and S. Fichtlscherer. 2006. The endothelium and inflammation. Endothelium 13: 423-429.
3. Berman, R. S., J. D. Frew, and W. Martin. 1993. Endotoxin-induced arterial endothelial barrier dysfunction assessed by an in vitro model. Br. J. Pharmacol. 110: 1282-1284.
4. Bannerman, D. D., and S. E. Goldblum. 1997. Endotoxin induces endothelial barrier dysfunction through protein tyrosine phosphorylation. Am. J. Physiol. 273: L217-L226.
5. Raetz, C. R. 1990. Biochemistry of endotoxins. Annu. Rev. Biochem. 59: 129-170.
6. Munshi, N., A. Z. Fernandis, R. P. Cherla, I. W. Park, and R. K. Ganju. 2002. Lipopolysaccharide-induced apoptosis of endothelial cells and its inhibition by vascular endothelial growth factor. J. Immunol. 168: 5860-5866.
7. Bierhaus, A., J. Chen, B. Liliensiek, and P. P. Nawroth. 2000. LPS and cytokineactivated endothelium. Semin. Thromb. Hemostasis 26: 571-587.
8. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15: 675-705.
9. Smart, S. J., and T B. Casale. 1993. Interleukin-8-induced transcellular neutrophil migration is facilitated by endothelial and pulmonary epithelial cells. Am. J. Respir. Cell Mol. Biol. 9: 489-495.
10. Smith, W. B., J. R. Gamble, I. Clark-Lewis, andM. A. Vadas. 1991. Interleukin-8 induces neutrophil transendothelial migration. Immunology 72: 65-72.
11. Avraham, H., S. Y. Park, K. Schinkmann, and S. Avraham. 2000. RAFTK/Pyk2- mediated cellular signalling. Cell Signal. 12: 123-133.
12. cas. J. Biol. Chem. 272: 228-232.
13. cas. Biochem. Biophys. Res. Commun. 290: 1470-1477.
14. 2+-induced regulation of ion channel and MAP kinase functions. Nature 376: 737-745.
15. Qian, D., S. Lev, N. S. van Oers, I. Dikic, J. Schlessinger, and A. Weiss. 1997. Tyrosine phosphorylation of Pyk2 is selectively regulated by Fyn during TCR signaling. J. Exp. Med. 185: 1253-1259.
16. Okazaki, H., J. Zhang, M. M. Hamawy, and R. P. Siraganian. 1997. Activation of protein-tyrosine kinase Pyk2 is downstream of Syk in FcεRI signaling. J. Biol. Chem. 272: 32443-32447.
17. Miyazaki, T., A. Takaoka, L. Nogueira, I. Dikic, H. Fujii, S. Tsujino, Y. Mitani, M. Maeda, J. Schlessinger, and T. Taniguchi. 1998. Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway. Genes Dev. 12: 770-775.
18. Tokiwa, G., I. Dikic, S. Lev, and J. Schlessinger. 1996. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science 273: 792-794.
19. Di Cioccio, V., R. Strippoli, C. Bizzarri, G. Troiani, M. N. Cervellera, I. Gloaguen, A. Colagrande, E. M. Cattozzo, S. Pagliei, A. Santoni, et al. 2004. Key role of proline-rich tyrosine kinase 2 in interleukin-8 (CXCL8/IL-8) -mediated human neutrophil chemotaxis. Immunology 111: 407-415.
20. Katagiri, T., T Takahashi, T. Sasaki, S. Nakamura, and S. Hattori. 2000. Proteintyrosine kinase Pyk2 is involved in interleukin-2 production by Jurkat T cells via its tyrosine 402. J. Biol. Chem. 275: 19645-19652.
21. Madry, H., M. Cucchiarini, E. F. Terwilliger, and S. B. Trippel. 2003. Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage. Hum. Gene Ther. 14: 393-402.
22. Tang, H., Q. Hao, T. Fitzgerald, T. Sasaki, E. J. Landon, and T. Inagami. 2002. Pyk2/CAKβ tyrosine kinase activity-mediated angiogenesis of pulmonary vascular endothelial cells. J. Biol. Chem. 277: 5441-5447.
23. Fuortes, M., M. Melchior, H. Han, G. J. Lyon, and C. Nathan. 1999. Role of the tyrosine kinase pyk2 in the integrin-dependent activation of human neutrophils by TNF. J. Clin. Invest. 104: 327-335.
24. Qi, J., S. Goralnick, and D. L. Kreutzer. 1997. Fibrin regulation of interleukin-8 gene expression in human vascular endothelial cells. Blood 90: 3595-3602.
25. Andreakos, E., S. M. Sacre, C. Smith, A. Lundberg, S. Kiriakidis, T. Stonehouse, C. Monaco, M. Feldmann, and B. M. Foxwell. 2004. Distinct pathways of LPS- induced NF-κB activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. Blood 103: 2229-2237.
26. Faure, E., O. Equils, P. A. Sieling, L. Thomas, F. X. Zhang, C. J. Kirschning, N. Polentarutti, M. Muzio, and M. Arditi. 2000. Bacterial lipopolysaccharide activates NF-κB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells: differential expression of TLR-4 and TLR-2 in endothelial cells. J. Biol. Chem. 275: 11058-11063.
27. Yang, R. B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395: 284-288.
28. Uehara, A., S. Yang, Y. Fujimoto, K. Fukase, S. Kusumoto, K. Shibata, S. Sugawara, and H. Takada. 2005. Muramyldipeptide and diaminopimelic acidcontaining desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell Microbiol. 7: 53-61.
29. Yang, S., R. Tamai, S. Akashi, O. Takeuchi, S. Akira, S. Sugawara, and H. Takada. 2001. Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect. Immun. 69: 2045-2053.
30. Dikic, I., G. Tokiwa, S. Lev, S. A. Courtneidge, and J. Schlessinger. 1996. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383: 547-550.
31. Schumann, R. R., D. Pfeil, N. Lamping, C. Kirschning, G. Scherzinger, P. Schlag, L. Karawajew, and F. Herrmann. 1996. Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14. Blood 87: 2805-2814.
32. Hashimoto, S., Y. Gon, K. Matsumoto, S. Maruoka, I. Takeshita, S. Hayashi, Y. Asai, I. Jibiki, T. Machino, and T. Horie. 2000. Selective inhibitor of p38 mitogen-activated protein kinase inhibits lipopolysaccharide-induced interleukin-8 expression in human pulmonary vascular endothelial cells. J. Pharmacol. Exp. Ther. 293: 370-375.
33. Hippenstiel, S., S. Soeth, B. Kellas, O. Fuhrmann, J. Seybold, M. Krull, C. Eichel-Streiber, M. Goebeler, S. Ludwig, and N. Suttorp. 2000. Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells. Blood 95: 3044-3051.
34. Rocic, P., G. Govindarajan, A. Sabri, and P. A. Lucchesi. 2001. A role for PYK2 in regulation of ERK1/2 MAP kinases and PI 3-kinase by ANG II in vascular smooth muscle. Am. J. Physiol. 280: C90-C99.
35. 1 integrin fibronectin receptor cross-linking and association with paxillin in human natural killer cells. J. Immunol. 159: 4729-4736.
36. Anfosso, F., N. Bardin, E. Vivier, F. Sabatier, J. Sampol, and F. Dignat-George. 2001. Outside-in signaling pathway linked to CD146 engagement in human endothelial cells. J. Biol. Chem. 276: 1564-1569.
37. Zheng, C., Z. Xing, Z. C. Bian, C. Guo, A. Akbay, L. Warner, and J. L. Guan. 1998. Differential regulation of Pyk2 and focal adhesion kinase (FAK) : the C- terminal domain of FAK confers response to cell adhesion. J. Biol. Chem. 273: 2384-2389.
38. Schaller, M. D., and T. Sasaki. 1997. Differential signaling by the focal adhesion kinase and cell adhesion kinase β. J. Biol. Chem. 272: 25319-25325.
39. Basile, J. R., T. Afkhami, and J. S. Gutkind. 2005. Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Mol. Cell Biol. 25: 6889-6898.
40. Kuwabara, K., T. Nakaoka, K. Sato, T. Nishishita, T. Sasaki, and N. Yamashita. 2004. Differential regulation of cell migration and proliferation through prolinerich tyrosine kinase 2 in endothelial cells. Endocrinology 145: 3324-3330.
41. Pauls, E., J. Senserrich, M. Bofill, B. Clotet, and J. A. Este. 2007. Induction of interleukins IL-6 and IL-8 by siRNA. Clin. Exp. Immunol. 147: 189-196.
42. Rock, F. L., G. Hardiman, J. C. Timans, R. A. Kastelein, and J. F. Bazan. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95: 588-593.
43. Hoffmann, J. A., F. C. Kafatos, C. A. Janeway, and R. A. Ezekowitz. 1999. Phylogenetic perspectives in innate immunity. Science 284: 1313-1318.
44. q -mediated pathways on calcium/calmodulin, Pyk2, and Src kinase. J. Biol. Chem. 272: 19125-19132.
45. Kotlyarov, A., A. Neininger, C. Schubert, R. Eckert, C. Birchmeier, H. D. Volk, and M. Gaestel. 1999. MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis. Nat. Cell Biol. 1: 94-97.
46. Munoz, C., D. Pascual-Salcedo, M. C. Castellanos, A. Alfranca, J. Aragones, A. Vara, J. M. Redondo, and M. O. de Landazuri. 1996. Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocytemacrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-κB and AP-1 transcription factors activity. Blood 88: 3482-3490.